Cipepofol Impurity 4 | CAS 1637742-30-3 - Request Quote
Cipepofol Impurity 4
| SZ CAT No: | SZ-C283005 |
| CAS No | 1637742-30-3 |
| Mol.F. | C13H16O2 |
| Mol.Wt. | 204.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cipepofol Impurity 4 is chemically Cyclopropyl(2-hydroxy-3-isopropylphenyl)methanone. Cipepofol Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Cipepofol Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cipepofol.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1637742-30-3
Purchase 1637742-30-3
Order 1637742-30-3
Enquire 1637742-30-3
price of 1637742-30-3
1637742-30-3 Supplier
1637742-30-3 Manufacturer
1637742-30-3 Exporter
buy high quality Cipepofol Impurity 4
Purchase Cipepofol Impurity 4
Cipepofol Impurity 4 suppliers
Cipepofol Impurity 4 manufacturers
Cipepofol Impurity 4 price
Order Cipepofol Impurity 4
Enquire Cipepofol Impurity 4
Cipepofol Impurity 4 cost
Cipepofol Impurity 4 Supplier
Cipepofol Impurity 4 Distributor
Cipepofol Impurity 4 for Method Validation
Cipepofol Reference Standard
Cipepofol Impurity 4 for ANDA Filing
Cipepofol Impurity 4 for Forced Degradation Studies
Cipepofol Impurity 4 Identification Standards
Cipepofol Impurity 4 for DMF Filing
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.